Close

content

Lexicon Pharmaceuticals acquires exclusive rights to development candidate for Neuropathic pain from its alliance with Bristol-Myers Squibb

Lexicon Pharmaceuticals Inc announced that it has obtained exclusive research, development and commercialization rights to LX9211 (BMS-986176), a development candidate for neuropathic pain that...

Cytokinetics announces new results from Cosmic-Hf to be presented at the American Heart Association Scientific Sessions 2016

Cytokinetics announced that a new analysis of left atrial structure and function from COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility in...

Genfit says FDA has officially cleared the IND to proceed with Phase II trial and evaluate elafibranor in PBC

GENFIT a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or...

Ashland announces strategic collaboration with HP Inc on adhesives and coatings for labels and flexible packaging

Ashland has announced a strategic collaboration with HP Inc.to develop laminating adhesives and coatings that are compatible with HP Indigo ElectroInk, reinforcing the viability of...

Spark Therapeutics and Pfizer Announce Updated Data from Hemophilia B Phase 1/2 Trial Suggesting Sustained Therapeutic Levels of Factor IX Activity

Spark Therapeutics and Pfizer Inc announced that Lindsey A. George, M.D a hematologist and attending physician at the Children’s Hospital of Philadelphia and lead...

Mallinckrodt To Present At 28th Annual Piper Jaffray Healthcare Conference

Mallinckrodt Pharmaceuticals a leading global specialty pharmaceutical company, will present on Wednesday, Nov. 30, 2016, at the 28th Annual Piper Jaffray Healthcare Conference at...

Amgen To Present At The Credit Suisse 25th Annual Healthcare Conference

Amgen will present at the Credit Suisse 25th Annual Healthcare Conference at 9 a.m. MT on Tuesday, Nov. 8, 2016, in Scottsdale, Ariz. David...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read